Testimonial No. 1, re. Interim Management in Medical Technology / Tele-Medicine:
Thomas Krause, General Manager, Brandenburg Capital:
... The 3-year activity of the interim CEO / CFO of S & P has always been characterized by the interests of the shareholders and investors, and always competently and hands-on.
As a long-term management company of venture capital funds, we invest among other things also in start-up companies with a promising profile in the field of medical technology and digital health.
In doing so, these companies usually develop through their life cycle from initially R & D-driven structures to sales and marketing organizations.
At one of our portfolio companies in "innovative Medical Technology / Tele-Medicine", the need for this turning point was to fill the management board quickly by means of an external CEO / CFO interim position, in order to create basic conditions for the first market launch. We have used S & P to obtain highly competent management resources that have allowed the company to make the necessary adjustments. This included, among others, the creation of a functioning organizational unit, the carrying out of market analyzes, the development of marketing and sales strategies and the securing of supply chain management / market supply.
Based on the collaboration with S & P, our portfolio company has succeeded in developing strategic partnerships, among others, with a GKV insurance company and to bring another investor on board.
The 3-year activity of the Interim CEO / CFO of S & P has always been characterized by the interests of the shareholders and investors, and always competently and hands-on.
In the meantime, the CEO interim function was handed over to the subsequent management, which, thanks to the preparation of S & P, was able to build on a good initial situation and successfully develop the company.
Testimonial No. 2, re. Interim Management in Medical Technology / Tele-Medicine:
Prof. Rust, Berlin:
“S & P GmbH has provided an experienced and competent Interim CEO (Dr. Mertens) for a life science company in a difficult situation for the company. Dr. Mertens has brought the company energetically on course. Foresighted analytics and strategy go hand in hand. The collaboration was characterized by mutual trust, and I can recommend S & P and Dr. Mertens to accompany life science companies at any time.
Testimonial No. 3, re. Interim Management in Medical Technology / Tele-Medicine:
Frank Michalak, Chairman of the Board / CEO of the AOK North-East:
Dr. Mertens from S & P is a professional and works with a very focused and purpose-oriented working approach. His experience contributed significantly to the fact that the start-up company EMPERRA was able to realize the pilot project with the AOK Nordost. Even when difficulties arose, he succeeded in bringing the 3 ½ years process to success through his gainful human behaviour.
Dr. Mertens (Interim CEO, provided by S & P GmbH for EMPERRA) was the driver that a telemedical high-tech product of the start-up company Emperra could be integrated into a health insurance funded program. He has developed a pure medical product into a healthcare product.
I myself - but also various teams from the AOK North-East - have worked together with Dr. Mertens over 3 ½ years for this project.
Due to the uniqueness of the product, and because of the novelty of tele-medical applications in the field of GKV-insurances, many challenges were overcome. Dr. Mertens was the connector and the driver on the side of Emperra and stood with high commitment behind the project with the AOK North-East.
Dr. Mertens is a professional and is characterized by a very focused and purpose-oriented working approach.
His experiences contributed significantly to the fact that the start-up company was able to realize the pilot project with the AOK North-East. He was able to provide an excellent link between a young company and a public body.
Such a project with partners of this kind, i.e. a company from the free economy and a corporation of public law, does not come forward without mutual trust in the abilities and risk-friendliness of the other. This, in turn, I experienced in the collaboration with Dr. Mertens.
The commitment of Dr. Mertens was characterized by mutual understanding and the idea that the pilot project will be realized for both sides. Even when difficulties arose, he succeeded in bringing the 3 ½ years process to success through his gainful human behaviour.